MAIN DIRECTIONS OF THE PROGRAM
Multiple sclerosis and other demyelinating processes - from a molecule to a patient (brain mechanisms, microbiota, disability, movement disorders)
New opportunities for the diagnosis and treatment of MS
Peculiarities of using DMTRS in Russia, clinical trials, routine practice
Issues of optimizing therapy, prescribing and switching DMTs
Patient management during the coronavirus pandemic and in the post-pandemic period
Complex clinical cases - solution algorithms
Ethical Issues in Conducting Scientific Clinical Research
Topical issues of activities of public organizations of researchers, doctors and patients with MS